echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > The Production Process of (±)-Orphenadrine

    The Production Process of (±)-Orphenadrine

    • Last Update: 2023-05-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The Production Process of (±)-Orphenadrine: An Overview of Chemical Industry


    Orphenadrine is a pharmaceutical drug that is primarily used to treat symptoms of Parkinson's disease, such as tremors and stiffness.
    The drug is a synthetic compound that is derived from a natural substance called strychnine, which is obtained from the seeds of the Strychnine tree.
    The production process of (±)-orphenadrine involves several steps, including the synthesis of the drug's starting material, the isolation and purification of the drug, and the formulation and packaging of the final product.


    The synthesis of the starting material for the production of (±)-orphenadrine involves the use of several chemical reactions.
    The synthesis starts with the conversion of spermine, a naturally occurring compound found in small amounts in many animal tissues, into spermine hydrochloride.
    This is followed by a series of chemical reactions that result in the formation of the starting material for the production of (±)-orphenadrine.
    The synthesis of the starting material is a crucial step in the production process, as it determines the quality and purity of the final product.


    Once the starting material has been synthesized, it is isolated and purified through a series of chromatographic techniques.
    The first step in the purification process is gel filtration, which separates the starting material from other impurities based on size.
    The purified starting material is then subjected to high-performance liquid chromatography (HPLC), which separates the starting material based on its chemical properties.
    This results in the isolation of the pure starting material, which is then used in the next step of the production process.


    The isolation and purification of (±)-orphenadrine is a critical step in the production process, as it ensures that the final product is safe and effective.
    The HPLC method used to purify the starting material is highly efficient and results in a product that is of a high purity.
    This is essential for the drug to be effective in treating the symptoms of Parkinson's disease.


    Once the starting material has been purified, it is combined with other chemicals to form the final product, (±)-orphenadrine.
    This involves the use of


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.